CLINICAL HIV AND AIDS JOURNAL (ISSN:2633-5476)

Aims and Scope

The journal welcomes original research articles, clinical studies, systematic reviews, case reports, and perspectives in areas including, but not limited to:

• Epidemiology and transmission dynamics of HIV

• Clinical management of HIV/AIDS and opportunistic infections

• Antiretroviral therapy (ART): advancements, efficacy, and challenges

• HIV drug resistance, pharmacology, and novel treatment approaches

• HIV-associated co-infections (e.g., tuberculosis, hepatitis, STIs)

• HIV immunology, virology, and vaccine development

• Prevention strategies: PrEP, PEP, mother-to-child transmission prevention

• Psychosocial, behavioral, and societal aspects of living with HIV

• HIV and global health policy, stigma reduction, and community-based care

• Long-term outcomes and comorbidities in people living with HIV

• Advances in diagnostics, biomarkers, and monitoring tools

Why Publish with CHA Journal?

• Global Visibility – Open access ensures worldwide readership and high citation potential.

• Rigorous Peer Review – Double-blind review process ensures unbiased and high-quality evaluation.

• Multidisciplinary Scope – Covers virology, immunology, clinical practice, public health, and policy.

• Rapid Publication – Accepted articles are published online quickly to disseminate findings without delay.

• Expert Editorial Oversight – Guided by an international panel of HIV specialists and public health experts.

• Author Benefits – Authors retain copyright under Creative Commons licensing, ensuring maximum use and reuse.

• Diverse Formats – Publishes research in PDF, HTML, and supplementary digital content.

Editorial & Ethical Standards

CHAJ strictly adheres to COPE and ICMJE guidelines to maintain the highest standards of integrity, ethics, and transparency in publishing.